Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
19.84
-0.44 (-2.17%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Assembly Biosciences Market Cap
Assembly Biosciences has a market cap or net worth of $403.95 million as of October 23, 2026. It is the 16,064th most valuable company in the world and the 2,888th biggest in the United States. Its market cap has increased by 87.02% in one year.
Market Cap
403.95M
Enterprise Value
85.94M
1-Year Change
87.02%
Global Rank
Country Rank
#2,888 United States
Category
ChartMarket Cap Chart
Since December 17, 2010, Assembly Biosciences's market cap has increased from $40.20M to $403.95M, an increase of 904.86%. That is a compound annual growth rate of 15.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 403.95M | -24.90% |
| Dec 31, 2025 | 537.90M | 436.29% |
| Dec 31, 2024 | 100.30M | 86.09% |
| Dec 29, 2023 | 53.90M | -14.98% |
| Dec 30, 2022 | 63.40M | -43.14% |
| Dec 31, 2021 | 111.50M | -44.19% |
| Dec 31, 2020 | 199.80M | -62.51% |
| Dec 31, 2019 | 532.90M | -7.48% |
| Dec 31, 2018 | 576.00M | -26.83% |
| Dec 29, 2017 | 787.20M | 276.11% |
| Dec 30, 2016 | 209.30M | 61.75% |
| Dec 31, 2015 | 129.40M | 54.60% |
| Dec 31, 2014 | 83.70M | 5.02% |
| Dec 31, 2013 | 79.70M | 185.66% |
| Dec 31, 2012 | 27.90M | -71.93% |
| Dec 30, 2011 | 99.40M | 135.55% |
| Dec 31, 2010 | 42.20M | 4.98% |
| Dec 17, 2010 | 40.20M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 432.32M |
| Allogene Therapeutics | 431.86M |
| ARS Pharmaceuticals | 429.61M |
| Prothena Corporation | 423.53M |
| Altimmune | 422.10M |
| Autolus Therapeutics | 420.54M |
| TRex Bio | 417.29M |
| Tectonic Therapeutic | 412.30M |